Patents by Inventor Kyungjin Kim
Kyungjin Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200377498Abstract: Provided is a novel pyrrolopyridine compound represented by Chemical Formula I, a racemate or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof; and to a method for preparing the same. A compound represented by Chemical Formula I shows high selectivity and antiviral activity against human immunodeficiency virus (HIV), with low toxicity; therefore, it is useful as a therapeutic agent for viral infection, in particular, HIV infection.Type: ApplicationFiled: March 24, 2017Publication date: December 3, 2020Applicant: ST PHARM CO., LTD.Inventors: Bong Jin KIM, Ill Young LEE, Jae Hak KIM, Hong Suk SHIN, Jong Chan SON, Chong-Kyo LEE, Kyungjin KIM, Uk-Il KIM, Hwa Jung NAM
-
Patent number: 10702546Abstract: The present invention relates to a method for preparing an end site-specific macromolecule-bile acid oligomer conjugate, comprising conjugating a bile acid oligomer which is prepared by oligomerization of two or more bile acid monomers to the terminal site of a macromolecule; a method for body absorption of an end site-specific macromolecule-bile acid oligomer conjugate, comprising administering the macromolecule-bile acid oligomer conjugate prepared by the above method to a subject orally; an end site-specific macromolecule-bile acid oligomer conjugate wherein the bile acid oligomer is conjugated to the terminal site of macromolecule; a composition comprising the conjugate; an oral formulation for macromolecule comprising the conjugate, a solubilizer, an excipient, a disintegrant, a binder, and a lubricant; a pharmaceutical composition comprising a heparin-bile acid oligomer conjugate wherein the bile acid oligomer is conjugated to the terminal site of heparin; and a method for treating thrombosis using saidType: GrantFiled: November 29, 2012Date of Patent: July 7, 2020Assignee: ST PHARM CO., LTD.Inventors: Young Ro Byun, Al-Hilal Taslim Ahmed, Ok Cheol Jeon, Hyun Tae Moon, Kyungjin Kim, Jisuk Yun
-
Publication number: 20200210096Abstract: Disclosed are devices, systems and methods for improving the reliability of retrieving information from a memory device. An exemplary method includes obtaining a plurality of cell counts for each of a plurality of read voltages applied to the memory device, each of the plurality of cell counts representing a number of cells having a cell voltage value that is within a voltage band corresponding to the read voltage applied thereto, generating, based on the plurality of cell counts, the plurality of read voltages and a design parameter, a set of estimated parameters, the design parameter being based on one or more properties of the memory device, determining an updated read voltage based on the estimated set of parameters, and applying the updated read voltage to the memory device to retrieve the information from the memory device.Type: ApplicationFiled: December 9, 2019Publication date: July 2, 2020Inventors: Yongjune Kim, Kyungjin Kim
-
Patent number: 10385022Abstract: This invention relates to novel 3-aminopyridines of the formula wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.Type: GrantFiled: February 6, 2015Date of Patent: August 20, 2019Assignee: HOFFMANN-LA ROCHE INC.Inventors: Caterina Bissantz, Henrietta Dehmlow, Shawn David Erickson, Prabha Saba Karnachi, Kyungjin Kim, Rainer E. Martin, Patrizio Mattei, Ulrike Obst Sander, Sherrie Lynn Pietranico-Cole, Hans Richter, Christoph Ullmer
-
Patent number: 10336765Abstract: The present invention relates to a novel dihydropyranopyrimidinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.Type: GrantFiled: December 1, 2016Date of Patent: July 2, 2019Assignee: ST. PHARM CO., LTD.Inventors: Kyungjin Kim, Uk-Il Kim, Ji Hye Yoon
-
Publication number: 20190024292Abstract: A laundry treating apparatus includes a tub, a drum, a cover defining a detergent inlet, a storage body configured to store the detergent, a barrier partitioning an interior of the storage body into first and second detergent spaces, a storage unit water supply nozzle configured to supply water to the first detergent space, a first body through hole defined at a bottom surface of the storage body, a first discharge pipe, a second discharge pipe, a siphon formation pipe surrounding the first discharge pipe and being configured to flow liquid from the first detergent space to the first body through hole based on a liquid level inside the first detergent space, and a space communication unit configured to flow liquid from the first detergent space to the second detergent space based on liquid not being discharged to an outside of the first detergent space through the first body through hole.Type: ApplicationFiled: October 23, 2017Publication date: January 24, 2019Inventors: Jihong LEE, Kyungjin KIM
-
Publication number: 20180362538Abstract: The present invention relates to a novel dihydropyranopyrimidinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.Type: ApplicationFiled: December 1, 2016Publication date: December 20, 2018Inventors: Kyungjin KIM, Uk-Il KIM, Ji Hye YOON
-
Publication number: 20180214559Abstract: The present invention provides a novel drug delivery conjugated moiety for oral administration of a drug that is not suitable for oral administration or a pharmaceutically acceptable salt thereof. When the drug delivery conjugated moiety of the present invention or a pharmaceutically acceptable salt thereof is combined with a drug, which is not suitable for oral administration, and is administered orally, it exhibits an excellent absorption rate without decreasing the biological activities of the drug. Moreover, the drug delivery conjugated moiety of the present invention or a pharmaceutically acceptable salt thereof can be easily prepared in a few steps, which is very advantageous in terms of mass production.Type: ApplicationFiled: July 20, 2015Publication date: August 2, 2018Inventors: Kyungjin KIM, Jisuk YUN, Hyukjun JUNG, Myungyun LEE, Hwajung NAM, Ok-cheol JEON
-
Patent number: 9580411Abstract: The invention is concerned with the compounds of formula (I): and salts thereof, wherein X, Y, Z, R1, R2, R3, R3?, R4, R5 and R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of Formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.Type: GrantFiled: March 27, 2015Date of Patent: February 28, 2017Assignee: Hoffmann-La Roche Inc.Inventors: Christine E. Brotherton-Pleiss, Huifen Chen, Shaoqing Chen, Zhi Chen, Shawn David Erickson, Anthony Estrada, Kyungjin Kim, Hongju Li, Allen John Lovey, Joseph P. Lyssikatos, Yimin Qian, Sung-Sau So, Peter Michael Wovkulich, Lin Yi
-
Patent number: 9495006Abstract: The present disclosure is directed to a display device and a method of controlling the display device. The display device includes a memory that stores at least one first gesture image corresponding to at least one function, a camera that obtains a basic image including user's second gesture image, and a controller that extracts the second gesture image from the basic image and displays at least one third gesture image similar to the extracted second gesture image, wherein the third gesture image is included in the first gesture image stored in the memory. The display device and method of controlling the display device may guide a user to make a correct gesture by displaying a gesture image similar to a gesture made by the user among gesture images stored in a memory.Type: GrantFiled: November 3, 2010Date of Patent: November 15, 2016Assignee: LG ELECTRONICS INC.Inventors: Soungmin Im, Jiyoung Hong, Minsun Kim, Kyungjin Kim
-
Patent number: 9353096Abstract: The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Y, R1, R2 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.Type: GrantFiled: April 10, 2015Date of Patent: May 31, 2016Assignee: Hoffmann-La Roche Inc.Inventors: Christine E. Brotherton-Pleiss, Zhi Chen, Shawn David Erickson, Kyungjin Kim, Hongju Li, Yimin Qian, Sung-Sau So, Peter Michael Wovkulich, Lin Yi
-
Patent number: 9226020Abstract: An NFC-enabled electronic device and a method for operating the same are discussed. The method according to an embodiment includes performing, by the electronic device, tagging with a first external device to establish communication with the first external device; receiving, by the electronic device, at least one of device information and user information from the first external device through the communication; and transmitting, by the electronic device, a remote control signal to at least one second external device, based on the at least one of the device information and the user information.Type: GrantFiled: April 30, 2012Date of Patent: December 29, 2015Assignee: LG ELECTRONICS INC.Inventors: Jongcheol Kim, Kyungjin Kim, Jinyung Park, Sungjong Park, Eunji Lee, Sungeun Kim, Ashesh Chagana Boyana, Srikanta Satapathy, Ramesh Venkatachalapathy
-
Patent number: 9165398Abstract: Data analysis of a food item based on one or more digital images of the food item is disclosed. In one embodiment, the method comprises displaying, on a display unit of the smart device, first and second digital images of a meal, where the first digital image is captured before the second digital image. The method also comprises determining a volume of each food item in the first digital image and a volume of each food item in the second digital image by analyzing the first digital image and the second digital image using a digital image processing technique. The method further comprises generating, on the display unit, an amount of intake for the meal based on a difference between the volume of each food item in the first digital image and the volume of each food item in the second digital image.Type: GrantFiled: February 25, 2011Date of Patent: October 20, 2015Assignee: LG ELECTRONICS INC.Inventors: Kyungjin Kim, Kiwon Lee, Sungil Cho, Jiyoung Hong, Sungeun Kim
-
Publication number: 20150290335Abstract: The present invention relates to a method for preparing an end site-specific macromolecule-bile acid oligomer conjugate, comprising conjugating a bile acid oligomer which is prepared by oligomerization of two or more bile acid monomers to the terminal site of a macromolecule; a method for body absorption of an end site-specific macromolecule-bile acid oligomer conjugate, comprising administering the macromolecule-bile acid oligomer conjugate prepared by the above method to a subject orally; an end site-specific macromolecule-bile acid oligomer conjugate wherein the bile acid oligomer is conjugated to the terminal site of macromolecule; a composition comprising the conjugate; an oral formulation for macromolecule comprising the conjugate, a solubilizer, an excipient, a disintegrant, a binder, and a lubricant; a pharmaceutical composition comprising a heparin-bile acid oligomer conjugate wherein the bile acid oligomer is conjugated to the terminal site of heparin; and a method for treating thrombosis using saidType: ApplicationFiled: November 29, 2012Publication date: October 15, 2015Inventors: Young Ro Byun, AI-Hilal Taslim Ahmed, Ok Cheol Jeon, Hyun Tae Moon, Kyungjin Kim, Jisuk Yun
-
Publication number: 20150218144Abstract: The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Y, R1, R2 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.Type: ApplicationFiled: April 10, 2015Publication date: August 6, 2015Applicant: Hoffmann-La Roche Inc.Inventors: Christine E. Brotherton-Pleiss, Zhi Chen, Shawn David Erickson, Kyungjin Kim, Hongju Li, Yimin Qian, Sung-Sau So, Peter Michael Wovkulich, Lin Yi
-
Publication number: 20150218141Abstract: The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein Y, R1 and R3 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists of the TRPA1 channel and may be useful in treating inflammatory diseases and disorders associated with that channel.Type: ApplicationFiled: April 16, 2015Publication date: August 6, 2015Applicant: HOFFMANN-LA ROCHE INC.Inventors: Christine E. Brotherton-Pleiss, Zhi Chen, Shawn David Erickson, Kyungjin Kim, Hongju Li, Allen John Lovey, Yimin Qian, Sung-Sau SO, Peter Michael Wovkulich, Lin Yi
-
Publication number: 20150197509Abstract: The invention is concerned with the compounds of formula (I): and salts thereof, wherein X, Y, Z, R1, R2, R3, R3?, R4, R5 and R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of Formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.Type: ApplicationFiled: March 27, 2015Publication date: July 16, 2015Applicants: GENENTECH, INC., HOFFMANN-LA ROCHE INC.Inventors: Christine E. BROTHERTON-PLEISS, Huifen CHEN, Shaoqing CHEN, Zhi CHEN, Shawn David ERICKSON, Anthony ESTRADA, Kyungjin KIM, Hongju LI, Allen John LOVEY, Joseph P. LYSSIKATOS, Yimin QIAN, Sung-Sau SO, Peter Michael WOVKULICH, Lin YI, I
-
Publication number: 20150152058Abstract: This invention relates to novel 3-aminopyridines of the formula wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.Type: ApplicationFiled: February 6, 2015Publication date: June 4, 2015Inventors: Caterina Bissantz, Henrietta Dehmlow, Shawn David Erickson, Prabha Saba Karnachi, Kyungjin Kim, Rainer E. Martin, Patrizio Mattei, Ulrike Obst Sander, Sherrie Lynn Pietranico-Cole, Hans Richter, Christoph Ullmer
-
Patent number: 8987307Abstract: This invention relates to novel 3-aminopyridines of the formula wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.Type: GrantFiled: February 28, 2012Date of Patent: March 24, 2015Assignee: Hoffmann-La Roche Inc.Inventors: Caterina Bissantz, Henrietta Dehmlow, Shawn David Erickson, Prabha Saba Karnachi, Kyungjin Kim, Rainer E. Martin, Patrizio Mattei, Ulrike Obst Sander, Sherrie Lynn Pietranico-Cole, Hans Richter, Christoph Ullmer
-
Publication number: 20140188485Abstract: Disclosed is a central controller, comprising: a microphone; an audio output unit configured to output audible information; a wireless communication unit configured to communicate with an electronic device using wireless signals; an event unit configured to receive event information on an event generated from the electronic device, through the wireless communication unit; and a controller configured to control the audio output unit based on the received event information, such that a guide voice indicating a status of the electronic device is output, wherein once a voice for controlling the electronic device is input to the microphone, the wireless communication unit is controlled such that a control command corresponding to the voice is transmitted to the electronic device.Type: ApplicationFiled: December 30, 2013Publication date: July 3, 2014Applicant: LG ELECTRONICS INC.Inventors: Kyungjin KIM, Daegu KIM, Yuvin HA, Junsoo PARK